Showing results (241-250 of 305) with videos related to

Sort By:
Pageof 31
Gynecologic Oncology|April 29, 2025
Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation: Final overall survival results from the OPINION trialAndrés Poveda, Stéphanie Lheureux, Nicoletta Colombo, et al.
Gynecologic Oncology|January 8, 2017
Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC)A Spreafico, A M Oza, B A Clarke, et al.
Cancer Research Communications|March 26, 2026
Pre-Clinical Combination Targeting VEGF and PI3K in a Rare, Aggressive Mixed Endometrial Carcinoma: An Applied Case ReportNikolina Radulovich, Pamela Soberanis Pina, Molly L Udaskin, et al.
Future Oncology (London, England)|May 5, 2025
DOMENICA: dostarlimab versus chemotherapy alone in first-line MMR-deficient advanced endometrial cancer patientsFrançois Cherifi, Isabelle Ray-Coquard, Maria Jesus Rubio, et al.
Journal of Gynecologic Oncology|December 22, 2024
Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80)Jung-Yun Lee, David Tan, Isabelle Ray-Coquard, et al.
BJU International|November 5, 2013
Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 studyFlorence Joly, Remy Delva, Loïc Mourey, et al.
Nature Communications|May 13, 2026
Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trialAna C Veneziani, Stephanie Lheureux, Douglas G Millar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2025
Novel Systemic Anticancer Treatments and Health Services Use at the End of Life Among Adults With CancerJavaid Iqbal, Rahim Moineddin, Kieran L Quinn, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 20, 2019
TP53 mutations in high grade serous ovarian cancer and impact on clinical outcomes: a comparison of next generation sequencing and bioinformatics analysesVictoria Mandilaras, Swati Garg, Michael Cabanero, et al.
Obstetrics and Gynecology International|June 12, 2018
Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary PerspectiveYeh Chen Lee, Nazlin Jivraj, Catherine O'Brien, et al.
Pageof 31